Skip to main content

Table 4 Highest level of respiratory support and adjunctive therapies among neonates with composite respiratory morbidity

From: Short-term respiratory outcomes in late preterm infants

  34 35 36 LPI 37 38 39 40 41 TI
  n = 38 n = 38 n = 29 n = 105 n = 32 n = 28 n = 19 n = 28 n = 14 n = 121
Nasal oxygen** 0 (0.0) 1 (2.6) 2 (6.9) 3 (2.9) 5 (15.6) 2 (7.1) 3 (15.8) 5 (17.9) 3 (21.4) 18 (14.9)
N-CPAP*** 26 (68.4) 26 (68.4) 16 (55.2) 68 (64.8) 13 (40.6) 11 (39.3) 6 (31.6) 4 (14.3) 5 (35.7) 39 (32.2)
MV 7 (18.4) 4 (10.5) 2 (6.9) 13 (12.4) 5 (15.6) 2 (7.1) 2 (10.5) 5 (17.9) 2 (14.3) 16 (13.2)
Surfactant* 6 (15.8) 7 (18.4) 4 (13.8) 17 (16.2) 5 (15.6) 0 (0.0) 0 (0.0) 3 (10.7) 0 (0.0) 8 (6.6)
INO 0 (0.0) 2 (5.3) 2 (6.9) 4 (3.8) 3 (9.4) 0 (0.0) 0 (0.0) 2 (7.1) 0 (0.0) 5 (4.1)
Pleural drainage 6 (15.8) 1 (2.6) 1 (3.5) 8 (7.6) 5 (15.6) 1 (3.6) 0 (0.0) 1 (3.6) 1(7.1) 8 (6.6)
Data are expressed as absolute numbers and proportions (%) of observed data in each category. All tests refer to comparisons between late preterm infants (LPI) and term infants (TI).
  1. ***P < .001, using χ2or Fisher test as appropriate.
  2. **P < .01, using χ2or Fisher test as appropriate.
  3. *P < .05, using χ2or Fisher test as appropriate.